EUVIMEDEUVIMED entdecken
Crossref

Critical reappraisal of prognostic indicators for 949 mucinous appendiceal neoplasm patients

Paul H Sugarbaker, David Chang

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Paul H Sugarbaker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Program in Peritoneal Surface Malignancy, Washington Cancer Institute, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Appendiceal Neoplasms, Adenocarcinoma, Mucinous, Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Foundation for Applied Research in Gastrointestinal Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives The standard of care for treatment of an appendiceal mucinous neoplasm with peritoneal dissemination is cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). These two treatments are combined in the operating room. A crucial requirement for benefit long‐term is proper patient selection. Clinical and histopathologic prognostic indicators are used, along with the patient's fitness for surgery, to select patients to receive CRS and HIPEC.

Methods

This study seeks to identify the reliable prognostic indicators for four different groups of patients. They are (1) the low‐grade appendiceal mucinous neoplasms (LAMN) with a complete CRS, (2) the mucinous appendiceal adenocarcinomas (MACA) with complete CRS, (3) MACA with lymph node metastases (MACA‐LN) with complete CRS, and (4) all histologic subtypes with incomplete cytoreduction. The prognostic indicators were evaluated for their impact on overall survival in these four groups of patients.

Results

The completeness of cytoreduction (CC) score statistically significantly showed survival differences in all three histologic subtypes. The peritoneal cancer index (PCI) showed significance with LAMN and MACA‐LN but not with MACA and not with incomplete CRS. The prior surgical score (PSS) was a prognostic indicator that predicted the outcome with LAMN, MACA‐LN, and incomplete CRS patients but not with the MACA group. Patients who were symptomatic or who had extensive systemic chemotherapy before CRS had a significantly reduced survival.

Conclusion

The utility of prognostic indicators varied greatly within our four different groups of appendiceal mucinous neoplasms. CC score was always a reliable prognosticator. Surprisingly, PCI was not.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Appendiceal NeoplasmsAdenocarcinoma, MucinousCytoreduction Surgical ProceduresHyperthermic Intraperitoneal ChemotherapyHumansPrognosisFemaleMaleMiddle AgedPeritoneal NeoplasmsAgedAdultSurvival RateCombined Modality TherapyRetrospective Studies

Stichwörter der Autor:innen

HIPECcancer differentiationmitomycin Cperitoneal cancer indexperitonectomypositive lymph nodesprior surgical score

Autor:innen und Institutionen

  • Program in Peritoneal Surface Malignancy, Washington Cancer Institute, Washington, District of Columbia, USA.
  • Westat, Rockville, Maryland, USA.

Förderung

  • Foundation for Applied Research in Gastrointestinal Oncology

Zitieren

APA

Sugarbaker, P. H., & Chang, D. (2024). Critical reappraisal of prognostic indicators for 949 mucinous appendiceal neoplasm patients. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27682

Vancouver

Sugarbaker PH, Chang D. Critical reappraisal of prognostic indicators for 949 mucinous appendiceal neoplasm patients. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27682

BibTeX
@article{Sugarbaker2024,
  author = {Sugarbaker, Paul H and Chang, David},
  title = {Critical reappraisal of prognostic indicators for 949 mucinous appendiceal neoplasm patients},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27682}
}
Kostenlos starten →